New European Moditope® patent allowed for grant To download click here Wednesday 20 November 2019 10:32 Categories: Moditope News Regulatory News Year - 2019
Scancell at the frontier of cancer therapy The Shares magazine August 2019 Spotlight profile of Scancell. Click here to view. Friday 30 August 2019 17:00 Categories: Immunobody Moditope News Year - 2019
Shares Magazine Investor Presentation At the Forefront of Immuno-Oncology The Shares Magazine Investor Evening presentation from 17 July 2019 is now available. Click here to view. To review further documents and presentations, please click here. Wednesday 17 July 2019 13:00 Categories: Immunobody Modi-1 Moditope News Presentations SCIB1 Year - 2019
Scancell Establishes Clinical Advisory Board and Provides Update on Modi-1 Progress To download click here Friday 10 May 2019 13:00 Categories: Modi-1 Moditope News Regulatory News Year - 2019
Scancell adds six ‘world-leading’ cancer specialists to advisory board ahead of Modi-1 trial “The initial focus of the board will be to inform the clinical strategy for the planned Modi-1 clinical trial and to ensure the best possible outcome in several solid tumour indications” [View article] Friday 10 May 2019 10:45 Categories: Media Coverage Modi-1 Moditope Year - 2019
Scancell announces grant of Japanese patent that protects its Moditope immunotherapy programme To download click here Monday 8 April 2019 13:00 Categories: Moditope News Regulatory News Year - 2019
Professor Lindy Durrant receives Waldenström award from the Swedish Society of Oncology To download click here Thursday 21 March 2019 12:00 Categories: Moditope News Year - 2019
IP Portfolio Strengthened To download click here Wednesday 20 March 2019 12:00 Categories: Modi-1 Moditope News Regulatory News Year - 2019
Scancell strengthens IP with two “important” patent grants in US and Europe The US patent covers Modi-1, while the European patent relates to a monoclonal antibody called FG88 [View article] Wednesday 20 March 2019 11:55 Categories: Media Coverage Modi-1 Moditope Year - 2019
Scancell lauds another six months of progress The funds raised in the last year "will allow us to focus on initiating the planned Phase 2 clinical trial for our lead ImmunoBody, SCIB1, and to advance our Moditope products, Modi-1 and Modi-2, towards the clinic". [View article] Thursday 31 January 2019 13:41 Categories: Immunobody Media Coverage Modi-1 Modi-2 Moditope SCIB1 Year - 2019